Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",44402,3182,1.18 [1.13-1.22],4.66907262285676e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,44645,3208,1.38 [1.31-1.46],4.913320645794593e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,38472,2750,0.81 [0.74-0.88],6.335160303396049e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,45678,3271,1.35 [1.24-1.48],6.075315267530385e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",44645,3208,1.17 [1.10-1.25],5.775906704888743e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,45056,3215,2.00 [1.79-2.24],1.1677621606039134e-33
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,45489,3254,1.23 [1.18-1.29],3.2914381124708814e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,38317,2725,1.16 [1.08-1.23],8.39273509372185e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,38472,2750,1.42 [1.30-1.55],8.364646659717023e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,45137,3223,0.80 [0.73-0.87],2.567306535792728e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,45819,3275,1.29 [1.16-1.43],1.8625782229201128e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39445,2811,1.42 [1.27-1.60],4.002799223459389e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,46041,3298,0.67 [0.59-0.76],1.335234213751155e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,45287,3236,1.24 [1.15-1.34],1.7987706489810372e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,38472,2750,1.31 [1.19-1.44],4.7186285760056254e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,45624,3266,0.84 [0.78-0.90],8.399054753967172e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,39620,2822,1.80 [1.63-1.99],1.063061038169418e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,38587,2750,1.46 [1.25-1.69],1.2776284405897008e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,38752,2761,1.47 [1.35-1.60],3.621755019403478e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,45815,3283,0.79 [0.71-0.87],6.153106777772977e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,45287,3236,1.11 [1.06-1.15],9.251952693286044e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,45872,3277,2.58 [2.28-2.90],5.80129535701635e-54
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,44099,3163,1.14 [1.11-1.18],4.5564003378552216e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR3,Anterior gradient protein 3,44330,3178,1.13 [1.07-1.19],4.5079707084737175e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,45681,3278,1.47 [1.35-1.60],3.498594318615063e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRP,Agouti-related protein,45978,3292,1.15 [1.08-1.22],2.825230460513501e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,45489,3254,1.14 [1.10-1.19],1.4066357365213012e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",45210,3229,1.08 [1.05-1.11],4.093643175992849e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",45353,3256,1.19 [1.15-1.24],2.4060771584590697e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39549,2810,1.21 [1.13-1.31],2.715438304126013e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",45287,3236,1.20 [1.17-1.22],6.59407502960335e-54
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,45807,3271,1.79 [1.53-2.09],1.811618137799225e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOT,Angiomotin,38752,2761,0.79 [0.72-0.87],1.5808895244622342e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,45355,3245,1.35 [1.23-1.47],4.232562750566874e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,45872,3277,1.60 [1.48-1.73],5.491756088701311e-32
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,44835,3203,1.35 [1.22-1.51],2.916515746296428e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,45607,3272,1.35 [1.26-1.44],8.09888081234726e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,45872,3277,1.27 [1.17-1.37],6.978090143194923e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANPEP,Aminopeptidase N,45583,3263,1.31 [1.18-1.47],1.5020489373135133e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,44453,3192,1.16 [1.12-1.20],5.683571315069196e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APCS,Serum amyloid P-component,39326,2810,1.37 [1.23-1.52],1.8549023174909687e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,45489,3254,0.78 [0.73-0.83],6.289685579261973e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,45287,3236,1.55 [1.46-1.65],7.796571638075873e-43
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,45137,3223,1.91 [1.74-2.09],2.2046713153896654e-43
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,39652,2821,1.76 [1.54-2.01],4.597159525861162e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,39683,2839,1.30 [1.21-1.40],4.758422149708033e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",38587,2750,1.35 [1.22-1.49],5.141309801449991e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",45681,3278,1.41 [1.26-1.57],7.25705485842895e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,44402,3182,1.23 [1.18-1.29],2.1985072608874898e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,45137,3223,0.61 [0.56-0.66],7.501341487348413e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",45425,3259,1.23 [1.14-1.33],6.513369041895318e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,38752,2761,1.66 [1.44-1.91],2.675295009213048e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,45383,3254,1.34 [1.28-1.42],4.2053775133722095e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,45899,3284,2.15 [1.85-2.50],7.695464178430023e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,45892,3279,1.38 [1.31-1.45],1.1822047548632568e-36
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,45681,3278,1.39 [1.24-1.56],1.850985893503669e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,45425,3259,1.30 [1.20-1.40],6.357692281150136e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C19orf12,Protein C19orf12,44453,3192,1.11 [1.06-1.16],2.0560142758219973e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,45660,3270,1.18 [1.11-1.27],1.5606471066828792e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,38680,2756,0.85 [0.79-0.91],4.89596987266644e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,38724,2770,1.46 [1.31-1.64],9.001513907236333e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,45872,3277,0.73 [0.67-0.80],2.9621939820571352e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,46041,3298,1.54 [1.36-1.74],1.3246670816094928e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",44645,3208,1.13 [1.09-1.16],9.930726787322049e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,45354,3254,0.81 [0.77-0.85],1.5210855667834674e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,45059,3219,1.12 [1.07-1.18],7.196814160248392e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,45356,3237,1.50 [1.29-1.75],1.6053043486901365e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,45138,3231,1.19 [1.13-1.25],5.334841111969566e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,45872,3277,0.66 [0.60-0.72],1.4409618608116704e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,38587,2750,1.17 [1.09-1.25],8.321556146829253e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,45489,3254,1.45 [1.33-1.58],4.583580055030199e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,45978,3292,1.27 [1.17-1.38],7.337914977082905e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL14,C-C motif chemokine 14,45355,3245,1.21 [1.12-1.30],3.838949586660294e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,46041,3298,1.30 [1.21-1.39],2.5784371205625964e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,46041,3298,1.26 [1.18-1.34],1.219557863986999e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,45384,3257,1.15 [1.11-1.19],1.8675449002697055e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL18,C-C motif chemokine 18,44846,3217,1.10 [1.06-1.15],2.04954784346211e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL19,C-C motif chemokine 19,45892,3279,1.05 [1.03-1.08],2.895856416060611e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,45978,3292,1.19 [1.15-1.23],7.075043860137011e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,45681,3278,1.33 [1.25-1.41],8.299256042345103e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,45028,3232,1.32 [1.25-1.39],5.037901130825469e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,45681,3278,1.27 [1.18-1.37],1.0929882107593619e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,45978,3292,1.22 [1.15-1.30],2.3542399249964984e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,45489,3254,1.18 [1.12-1.24],1.4378903761812708e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,45286,3247,1.19 [1.13-1.25],2.708310041651084e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,45425,3259,1.15 [1.11-1.20],1.5405362502509058e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL5,C-C motif chemokine 5,45660,3270,1.09 [1.06-1.13],7.358794505429233e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,45425,3259,1.27 [1.21-1.33],1.382209968746793e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,45212,3229,1.14 [1.10-1.19],4.173559677874573e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,45966,3291,1.33 [1.22-1.46],3.9606056716363085e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,45872,3277,1.25 [1.16-1.35],8.495690335646435e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD101,Immunoglobulin superfamily member 2,39445,2811,1.25 [1.15-1.36],4.83753652699309e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,44555,3194,1.51 [1.41-1.63],5.523120894476535e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,45660,3270,1.20 [1.12-1.29],3.98070373896097e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD207,C-type lectin domain family 4 member K,44514,3181,1.20 [1.11-1.30],6.880988111653955e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,39620,2822,0.77 [0.71-0.84],3.024052749794729e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,45624,3266,1.44 [1.34-1.54],7.264452272903773e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,45137,3223,1.47 [1.34-1.60],1.0280873134234149e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,45892,3279,1.38 [1.27-1.51],2.050138557696643e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,45727,3266,1.44 [1.34-1.55],3.8271929380661154e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,45872,3277,1.17 [1.11-1.23],4.613090389469237e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,45287,3236,1.71 [1.55-1.88],7.930671543657954e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,45740,3272,0.73 [0.64-0.82],9.744361608328524e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,45358,3250,1.43 [1.32-1.55],6.9135280247538085e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,45456,3261,1.18 [1.11-1.25],8.84525494640402e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,45807,3271,1.32 [1.21-1.44],1.984466849647255e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,43817,3116,1.55 [1.35-1.77],1.5704171933112606e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD7,T-cell antigen CD7,38399,2746,1.21 [1.11-1.32],6.381733701342258e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,45892,3279,1.46 [1.34-1.59],1.0711900126508914e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,39619,2822,1.45 [1.30-1.60],3.1725885737871318e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,45425,3259,1.60 [1.48-1.74],8.314858923625585e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,45494,3263,1.77 [1.56-2.00],4.1548016336742374e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,45137,3223,1.46 [1.38-1.54],2.85536859365816e-44
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH1,Cadherin-1,43957,3146,1.18 [1.10-1.27],3.395672171125405e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,45489,3254,1.32 [1.21-1.44],3.227094630317555e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH5,Cadherin-5,46041,3298,0.79 [0.71-0.88],9.257604313301414e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,45287,3236,1.14 [1.09-1.19],1.3690953092299188e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,45555,3261,1.76 [1.53-2.03],2.456547679216995e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39445,2811,0.78 [0.74-0.81],6.920705306594017e-33
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,43836,3135,1.37 [1.31-1.43],5.855607426221572e-46
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39620,2822,1.48 [1.38-1.58],1.9679282501479903e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,44645,3208,1.24 [1.17-1.31],1.389495614671036e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,45595,3270,1.13 [1.09-1.17],1.4420830788991275e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES2,Cocaine esterase,45287,3236,1.14 [1.08-1.20],1.0083459329589011e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,38971,2789,1.50 [1.34-1.68],1.3639225473193429e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFD,Complement factor D,39683,2839,1.48 [1.27-1.73],3.9803603811014653e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFH,Complement factor H,37400,2689,1.49 [1.27-1.75],1.2834672980650943e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,39683,2839,2.03 [1.69-2.43],1.602620763712553e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,45489,3254,1.27 [1.18-1.36],5.923840546731519e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAD,Chondroadherin,38752,2761,0.82 [0.77-0.88],7.871145303577831e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39522,2809,1.58 [1.46-1.71],9.035600229917536e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,39426,2798,1.61 [1.45-1.79],1.4795265680668485e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,39620,2822,1.18 [1.14-1.23],7.850102482346288e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,44464,3180,1.32 [1.27-1.36],3.659714594634985e-58
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,45607,3272,1.38 [1.26-1.52],5.4782029419239076e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,39620,2822,1.28 [1.19-1.37],7.564064694647556e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,45749,3273,1.68 [1.53-1.85],7.934140998779393e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,39620,2822,1.24 [1.17-1.32],1.7576711223996064e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,45137,3223,1.34 [1.23-1.46],5.547766456469479e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,45494,3263,1.38 [1.26-1.52],3.4969513013908654e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,38767,2773,0.55 [0.46-0.65],5.254157452735089e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,45425,3259,0.81 [0.74-0.88],1.7020608939647755e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,45425,3259,1.29 [1.23-1.35],2.569817429217665e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,45338,3243,1.67 [1.52-1.84],6.795723951537845e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,44402,3182,1.27 [1.19-1.36],3.1535711481569145e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,45978,3292,1.15 [1.09-1.22],8.480536970489176e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,38532,2753,1.24 [1.16-1.34],5.1988413673765325e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,45872,3277,1.71 [1.48-1.97],3.0031316789735336e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,45978,3292,1.25 [1.16-1.34],7.986103936771409e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLUL1,Clusterin-like protein 1,45412,3252,0.86 [0.80-0.92],9.44401872449374e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,46041,3298,0.60 [0.54-0.67],1.470433630947457e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,45590,3258,0.74 [0.68-0.80],1.8194848735368857e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,45665,3273,2.13 [1.87-2.43],1.836754964809401e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,45489,3254,1.25 [1.15-1.35],4.022422093374021e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,46041,3298,1.58 [1.45-1.72],1.1124212150400755e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,45463,3264,1.73 [1.54-1.94],5.761949352199459e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",38587,2750,1.22 [1.12-1.32],1.5284995362844223e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA1,Carboxypeptidase A1,46041,3298,1.12 [1.07-1.17],1.3404424142527426e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,45668,3260,1.39 [1.27-1.52],2.810458080088643e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR2,Complement receptor type 2,45660,3270,0.83 [0.78-0.89],9.00145149624948e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,44892,3222,1.33 [1.23-1.43],2.1664821567335923e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,38752,2761,1.35 [1.23-1.49],9.341434579692759e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,45607,3272,1.15 [1.08-1.22],5.124136737664927e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,45463,3264,1.37 [1.22-1.53],3.542389419091198e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,45681,3278,1.41 [1.21-1.65],9.592568574526052e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIP2,Cysteine-rich protein 2,45137,3223,1.27 [1.17-1.38],4.867283048689154e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,45872,3277,0.88 [0.84-0.92],5.496099183035716e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,39288,2788,0.74 [0.65-0.84],6.1415158130784285e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,45681,3278,1.50 [1.34-1.67],4.428763471434222e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,39620,2822,0.78 [0.70-0.86],2.10492986538164e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,45587,3265,1.72 [1.55-1.91],1.7926771106336765e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,45530,3267,1.10 [1.06-1.13],3.823543022696915e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,44839,3211,1.36 [1.27-1.46],3.683938319253401e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,39620,2822,1.44 [1.27-1.63],1.1829467138239926e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,39522,2809,0.89 [0.84-0.93],2.473234625203411e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,45377,3261,1.20 [1.12-1.29],1.1029944829571333e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,42499,3049,1.52 [1.43-1.62],2.1354354854586748e-40
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSF,Cathepsin F,45624,3266,1.26 [1.17-1.35],1.0463237082568475e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,45489,3254,1.63 [1.44-1.84],6.125669907289893e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,45978,3292,1.28 [1.16-1.41],2.948482607207338e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,45507,3259,1.42 [1.29-1.56],1.1173307759689121e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,45425,3259,1.39 [1.31-1.47],3.417319598552582e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,45892,3279,1.12 [1.07-1.17],1.5378209050216333e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,45964,3294,1.92 [1.69-2.18],4.029075874383994e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,45978,3292,1.68 [1.60-1.76],6.766740010379758e-93
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,45133,3237,1.15 [1.10-1.19],6.960908697595389e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,45681,3278,1.19 [1.14-1.24],1.830609966937666e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",45624,3266,1.25 [1.14-1.36],8.482143964547598e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",45287,3236,1.31 [1.23-1.40],1.1107075132150335e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,45892,3279,1.61 [1.42-1.82],1.14247019791887e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,44856,3211,1.06 [1.04-1.08],5.6177422842000885e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLK1,Protein delta homolog 1,46041,3298,0.88 [0.83-0.93],4.304800443174916e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,45624,3266,1.33 [1.20-1.47],3.2330207061229314e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,38587,2750,0.82 [0.78-0.87],2.807362247912647e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,45382,3260,0.73 [0.65-0.82],2.681048012728974e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP1,Dipeptidase 1,45059,3219,0.86 [0.80-0.91],1.521336645998768e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,45425,3259,1.43 [1.33-1.54],1.6304153017345076e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,45287,3236,0.67 [0.61-0.73],2.50245282275974e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,45126,3228,1.25 [1.19-1.32],8.899177908812481e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,45733,3269,1.17 [1.11-1.23],1.42191865956287e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,39351,2796,1.27 [1.18-1.38],1.3423827573287614e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,45287,3236,1.48 [1.31-1.67],1.0101724398506023e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39619,2822,1.21 [1.16-1.26],2.0644899822116602e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",38587,2750,1.13 [1.08-1.17],5.584399594315103e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,45872,3277,1.44 [1.32-1.56],3.206470732867452e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,44645,3208,1.38 [1.28-1.49],5.638674612082484e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,38587,2750,1.99 [1.76-2.24],1.8905984670704985e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,39445,2811,1.44 [1.28-1.61],3.7228653529178976e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,45584,3266,1.35 [1.23-1.49],1.4070436078761779e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,45417,3256,1.71 [1.54-1.90],7.423787120049644e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,45056,3215,1.62 [1.47-1.78],3.029806675869141e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,44402,3182,1.30 [1.20-1.40],8.305895594332628e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFLAM,Pikachurin,39445,2811,1.31 [1.17-1.46],2.272720250479223e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,46041,3298,0.43 [0.36-0.52],7.801150592590988e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,45425,3259,1.17 [1.12-1.22],1.1947034864092951e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,45489,3254,1.13 [1.08-1.19],7.937452325387111e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,39619,2822,1.44 [1.31-1.60],8.591785133372541e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,45681,3278,0.80 [0.75-0.86],1.102854954873709e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,44086,3158,1.18 [1.13-1.22],2.6258245624667095e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,43868,3120,1.48 [1.34-1.63],6.457273430693968e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA4,Ephrin type-A receptor 4,38752,2761,0.73 [0.65-0.83],1.4971490075813626e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,46041,3298,1.44 [1.28-1.62],1.1495319816347498e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,45425,3259,1.11 [1.06-1.15],2.886761795954232e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,45796,3273,1.42 [1.29-1.57],2.8329576690351484e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,45624,3266,1.48 [1.31-1.67],4.891666910003766e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,45892,3279,1.47 [1.30-1.65],2.6406260302514004e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11R,Junctional adhesion molecule A,45494,3263,1.13 [1.07-1.19],7.82738553955639e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,45586,3264,2.12 [1.79-2.52],8.288352397947059e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",45463,3264,1.18 [1.14-1.22],3.486672334387736e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",45489,3254,1.09 [1.05-1.13],1.9368532535291984e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",39619,2822,1.30 [1.21-1.38],1.488210860506445e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",46041,3298,1.36 [1.28-1.44],1.8224652264424545e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,45741,3272,1.13 [1.09-1.18],1.6780527440972722e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,39619,2822,1.88 [1.68-2.10],6.339771836345749e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,45287,3236,1.36 [1.24-1.48],2.476678028358449e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,45420,3249,1.47 [1.33-1.63],1.6405614868564397e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAP,Prolyl endopeptidase FAP,46041,3298,0.74 [0.66-0.82],7.544729794709912e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,45978,3292,0.77 [0.72-0.84],2.140548602340605e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",45489,3254,1.11 [1.07-1.16],4.844345389404581e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,45425,3259,1.18 [1.10-1.26],6.899442628669395e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,39581,2820,1.32 [1.23-1.41],4.5572680929481566e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,44402,3182,1.16 [1.10-1.22],2.368712002289178e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGA,Fibrinogen alpha chain,38758,2771,1.36 [1.20-1.53],4.634565550731525e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF19,Fibroblast growth factor 19,45681,3278,1.11 [1.06-1.15],5.18265555023606e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,45809,3273,1.22 [1.19-1.24],3.5654983377964363e-60
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,45800,3272,1.26 [1.20-1.32],1.2913236852660942e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,45624,3266,0.77 [0.71-0.85],2.773984316761872e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,45624,3266,1.74 [1.51-1.99],2.273818382432325e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,39652,2821,1.31 [1.24-1.38],1.4916625007515317e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FIS1,Mitochondrial fission 1 protein,45454,3263,1.10 [1.06-1.15],1.0082654105171543e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,45137,3223,1.18 [1.10-1.27],7.390926678402802e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,45607,3272,1.21 [1.14-1.29],3.5001100529597757e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,38587,2750,1.93 [1.65-2.25],5.401125623317986e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,45396,3255,1.94 [1.77-2.12],1.6587042235953615e-46
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,39447,2807,1.10 [1.06-1.15],1.8730134551922133e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,38752,2761,1.21 [1.14-1.28],6.538038576322415e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,45624,3266,1.43 [1.31-1.57],2.7757401436127853e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,45892,3279,1.39 [1.30-1.48],6.293152468883561e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAL,Galanin peptides,45681,3278,0.85 [0.81-0.89],4.318304423701639e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,45287,3236,1.61 [1.45-1.80],1.1170931996452797e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,45872,3277,0.74 [0.65-0.83],2.741874220831845e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,45744,3276,1.38 [1.22-1.56],1.6617747350668366e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,39522,2809,1.16 [1.13-1.19],8.360055356345343e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP1,Guanylate-binding protein 1,39455,2807,1.15 [1.09-1.21],1.0982541613688924e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCG,Pro-glucagon,44402,3182,1.06 [1.03-1.08],9.442576989970404e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37825,2699,1.34 [1.26-1.42],1.9869835410532337e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,46041,3298,1.72 [1.64-1.81],1.1978413627760282e-103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,44402,3182,1.19 [1.14-1.25],2.6563393557280897e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,45809,3273,1.73 [1.56-1.92],4.051507572550611e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,38359,2731,0.80 [0.76-0.85],1.2936873557386002e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,45417,3256,1.43 [1.36-1.51],2.1736345224744804e-37
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,45137,3223,1.51 [1.32-1.72],8.330812932738446e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,39522,2809,1.46 [1.30-1.63],2.205966574265589e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,38680,2754,1.39 [1.26-1.53],7.328905913735331e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,45137,3223,1.24 [1.15-1.33],8.568994927711631e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,44645,3208,1.20 [1.14-1.27],1.5588852437763255e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,38649,2747,1.29 [1.19-1.40],3.2023404968173077e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,45892,3279,1.52 [1.33-1.73],2.0656082029648727e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,39426,2798,1.26 [1.18-1.35],8.127297974921066e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,44453,3192,1.29 [1.19-1.41],3.2876341899544013e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,39445,2811,1.14 [1.08-1.21],7.001251252261576e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,44645,3208,1.27 [1.21-1.33],5.799550692390115e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,39426,2798,1.28 [1.21-1.36],8.721944570683413e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,45269,3249,1.51 [1.33-1.71],5.510754847162673e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",45287,3236,1.31 [1.25-1.38],7.961564986027272e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,39507,2806,0.52 [0.45-0.59],1.528796526947998e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,45678,3271,1.18 [1.13-1.24],3.312419737575192e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,45872,3277,1.09 [1.06-1.12],1.1431239599824196e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,45807,3271,1.37 [1.31-1.43],1.6354096170897055e-40
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,45494,3263,1.64 [1.50-1.78],9.672787659197872e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,38752,2761,1.50 [1.32-1.71],4.5608837968500486e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,45978,3292,1.70 [1.57-1.85],3.2167513050567543e-37
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,39447,2804,1.22 [1.15-1.30],8.66675673478333e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HJV,Hemojuvelin,39549,2810,1.23 [1.14-1.33],1.4992541368965568e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",45425,3259,1.38 [1.25-1.54],1.1127652597053999e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,44453,3192,1.20 [1.13-1.28],5.74799911418424e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,44918,3205,1.22 [1.14-1.30],1.650284746796033e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,44402,3182,0.71 [0.65-0.77],1.3565704928368237e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPSE,Heparanase,39108,2795,1.10 [1.06-1.14],1.9390270906742465e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,45287,3236,1.30 [1.19-1.41],8.949521217215396e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,45425,3259,1.25 [1.16-1.35],4.791811816176018e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39522,2809,1.16 [1.10-1.23],2.902917968416749e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,45129,3231,1.51 [1.35-1.70],2.1943681555801263e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,45230,3246,1.51 [1.33-1.71],1.2332893984051615e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,46041,3298,1.40 [1.22-1.60],1.5328125567661908e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,45280,3241,1.77 [1.61-1.95],3.97292081890611e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,45489,3254,1.49 [1.40-1.60],2.412542424066345e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,45872,3277,1.28 [1.20-1.37],2.33532233013238e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,38478,2739,1.70 [1.58-1.84],5.052011694933252e-41
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR2,Interferon gamma receptor 2,45137,3223,1.17 [1.11-1.24],5.1826186668219895e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNLR1,Interferon lambda receptor 1,45425,3259,1.22 [1.13-1.32],7.6042837540992e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39620,2822,0.66 [0.59-0.75],2.791565253272778e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,45494,3263,1.56 [1.36-1.77],3.90412938383665e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,45965,3293,1.08 [1.06-1.11],3.3988234537205314e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,45968,3295,1.21 [1.15-1.27],2.727467487092393e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,44907,3222,1.69 [1.59-1.80],2.9009958013792302e-64
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,46041,3298,1.65 [1.51-1.81],3.257997540901119e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,45489,3254,1.72 [1.58-1.87],5.649681269038977e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,39618,2833,1.44 [1.29-1.60],6.844396903689025e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,45287,3236,1.29 [1.19-1.40],6.24244534351708e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,45489,3254,1.58 [1.43-1.75],5.612808908261499e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,39619,2822,1.17 [1.13-1.22],5.4249106623992304e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,45681,3278,1.62 [1.47-1.79],4.061636209762957e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,45425,3259,1.70 [1.56-1.86],2.005046243232039e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,45313,3257,1.26 [1.18-1.34],5.289997755213448e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,45660,3270,1.46 [1.33-1.61],2.6907541155238985e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,45978,3292,1.31 [1.20-1.43],6.198285363166092e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,44352,3175,1.17 [1.12-1.22],3.744010754789078e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1B,Interleukin-1 beta,44406,3181,1.12 [1.07-1.18],4.5510033595957565e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,45417,3256,1.36 [1.19-1.55],8.546238777034778e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,45888,3286,1.29 [1.21-1.38],1.0679599266059608e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,44617,3192,0.78 [0.72-0.84],8.495988184398213e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,45376,3260,1.26 [1.20-1.32],2.6005648291953332e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,39426,2798,1.23 [1.18-1.29],4.693467149976333e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,45153,3237,1.49 [1.39-1.61],3.280804458326877e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,45425,3259,1.17 [1.10-1.26],4.061520393568167e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,45425,3259,1.52 [1.40-1.65],1.6256155674149562e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,45287,3236,1.23 [1.19-1.27],1.5710152543700515e-38
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,45494,3263,0.82 [0.78-0.87],1.2450160696730364e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,39426,2798,1.37 [1.28-1.47],8.304457553744642e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,38752,2761,1.39 [1.30-1.49],1.7095187617689129e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",38587,2750,1.15 [1.08-1.22],6.671664898475064e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL3,Insulin-like 3,39522,2809,0.90 [0.86-0.94],2.210606639791952e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,39445,2811,1.14 [1.10-1.18],8.599029524463548e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM1,Isthmin-1,45425,3259,1.21 [1.12-1.31],2.8578577874521467e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,45425,3259,0.72 [0.66-0.79],1.532405308660519e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,45494,3263,1.40 [1.24-1.58],5.731919870822773e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAM,Integrin alpha-M,45494,3263,0.76 [0.69-0.84],1.2558583242545072e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,45872,3277,0.55 [0.46-0.66],8.855106689120689e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,39620,2822,1.33 [1.21-1.46],1.593482413807546e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,45660,3270,1.34 [1.23-1.45],4.935170946791306e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,44617,3192,1.14 [1.09-1.20],2.999130923386368e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,45287,3236,0.83 [0.78-0.89],3.8506671858666944e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHK,Ketohexokinase,38587,2750,1.15 [1.08-1.22],2.918992968382272e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,45489,3254,0.67 [0.62-0.72],9.481191392251956e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLF4,Krueppel-like factor 4,38312,2731,1.21 [1.11-1.32],7.466362522775098e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,45488,3255,1.25 [1.16-1.35],2.132655644346182e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,45191,3230,1.30 [1.18-1.42],4.7180218385159175e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK13,Kallikrein-13,44484,3177,1.20 [1.12-1.28],5.5408758382636e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,45872,3277,1.21 [1.15-1.26],4.221383304044038e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK8,Kallikrein-8,43961,3140,1.24 [1.13-1.35],1.5841562713182793e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",45287,3236,1.16 [1.12-1.21],3.281478393115233e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",45353,3256,1.16 [1.11-1.21],8.981767995342759e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",38312,2731,1.12 [1.07-1.17],1.863470495196143e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,45978,3292,1.25 [1.17-1.33],4.1635906226032285e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,45463,3264,1.40 [1.31-1.50],5.571211291831423e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,45681,3278,1.32 [1.21-1.44],4.0955264643528455e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,45899,3284,1.51 [1.44-1.59],9.763407573328736e-57
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,45059,3219,1.45 [1.33-1.58],8.899566218348722e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,45892,3279,1.12 [1.07-1.16],9.567143664795097e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,44097,3162,1.26 [1.17-1.35],1.9596949765790504e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,39619,2822,1.18 [1.12-1.25],5.779341842732236e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,39549,2810,1.21 [1.13-1.29],7.451191069193143e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,45489,3254,1.34 [1.23-1.45],2.7038409680887185e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,45600,3263,1.36 [1.23-1.51],1.667548973767388e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,39683,2839,1.41 [1.27-1.56],6.145520144502754e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,45463,3264,1.41 [1.34-1.49],3.960200096624727e-38
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS7_LGALS7B,Galectin-7,45345,3241,1.18 [1.09-1.26],8.28201982450275e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,45456,3261,1.61 [1.47-1.77],6.98405631845248e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,45681,3278,1.49 [1.38-1.62],2.8245643893569108e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIF,Leukemia inhibitory factor,44453,3192,1.15 [1.08-1.21],2.9978541617674967e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,45420,3249,1.42 [1.29-1.57],3.344963251078037e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,45815,3283,1.23 [1.13-1.35],5.348424882136281e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,44617,3192,1.36 [1.27-1.46],1.9428434789565188e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,39522,2809,1.48 [1.31-1.67],3.130858798887996e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD1,Leiomodin-1,39549,2810,1.26 [1.15-1.38],8.875770216017427e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,39683,2839,1.75 [1.54-2.00],4.782498110650541e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,45489,3254,1.23 [1.13-1.34],1.882405215699025e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,45287,3236,1.31 [1.22-1.41],1.0844877070063456e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,44617,3192,0.65 [0.60-0.70],1.1345725726373283e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39549,2810,0.72 [0.62-0.83],6.1989585818936205e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,45872,3277,1.16 [1.11-1.21],2.009704412226933e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,46041,3298,1.42 [1.29-1.57],3.738450074209995e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,44402,3182,1.19 [1.13-1.26],1.5033067206110227e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,45236,3249,1.47 [1.33-1.64],6.273813455547408e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,45137,3223,1.31 [1.20-1.42],3.030043496396977e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,44980,3213,1.18 [1.12-1.24],6.233205487637267e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC4,Apical endosomal glycoprotein,39426,2798,1.24 [1.17-1.31],2.2999229536241515e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,39619,2822,1.15 [1.09-1.23],3.1037884830332737e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARCO,Macrophage receptor MARCO,45489,3254,1.33 [1.18-1.49],3.027923254043751e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,45535,3268,1.38 [1.25-1.53],7.231272276946818e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCAM,Cell surface glycoprotein MUC18,45660,3270,0.78 [0.71-0.86],1.937634559214496e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,45492,3254,1.31 [1.24-1.39],1.959220971987285e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,45888,3286,1.46 [1.26-1.70],6.898294032228667e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,45489,3254,0.92 [0.90-0.95],1.4437120234609895e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,45463,3264,0.69 [0.61-0.77],2.6779922796198287e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,45605,3264,0.58 [0.49-0.68],7.361822907040342e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,45494,3263,1.27 [1.19-1.36],2.6674371990258694e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,45287,3236,1.20 [1.16-1.25],1.9397397280075835e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP1,Interstitial collagenase,43842,3151,1.11 [1.07-1.15],3.304341246651236e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,45388,3259,1.19 [1.13-1.25],8.821977432028358e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,45528,3251,1.54 [1.47-1.63],2.8173610861178787e-60
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,45494,3263,1.17 [1.10-1.24],7.152765598962787e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,44576,3204,1.40 [1.31-1.49],8.777534771215891e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,45819,3275,1.17 [1.12-1.21],1.026344316958939e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,45424,3262,1.23 [1.17-1.30],2.3017410340273234e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,39652,2821,1.57 [1.39-1.77],4.829107433141823e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,45215,3232,1.31 [1.25-1.36],1.9515783585628808e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,45380,3254,1.20 [1.15-1.26],1.5527206758105955e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,45892,3279,1.35 [1.26-1.44],5.540206637995816e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,44645,3208,0.79 [0.75-0.84],3.567421424742673e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,38882,2775,1.19 [1.12-1.26],6.993917780738076e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,44453,3192,1.15 [1.09-1.22],2.6717142361849176e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,44617,3192,1.21 [1.17-1.26],7.045170085359731e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,38752,2761,0.71 [0.63-0.80],2.9863220599624025e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,45609,3274,1.36 [1.28-1.43],1.9163419587605787e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,45624,3266,1.44 [1.29-1.62],3.339983391705882e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM1,Neural cell adhesion molecule 1,45660,3270,0.73 [0.66-0.81],1.3205159979721343e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,45892,3279,0.72 [0.66-0.78],1.623933935686708e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,45420,3249,1.61 [1.46-1.78],1.9947472327489008e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,45624,3266,1.31 [1.19-1.44],3.2314013517541295e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,44318,3185,1.33 [1.25-1.43],1.1400772018941373e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,45624,3266,0.79 [0.74-0.85],3.4763860477298617e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,45978,3292,1.32 [1.19-1.47],1.9529262778372538e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",44617,3192,1.15 [1.09-1.20],1.0248298323494724e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,37837,2699,1.75 [1.55-1.97],3.403211553039431e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID1,Nidogen-1,45507,3257,1.21 [1.12-1.31],3.2150751180433834e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOMO1,Nodal modulator 1,45494,3263,1.36 [1.19-1.55],5.285624559681952e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,46041,3298,0.64 [0.52-0.77],5.05976086566244e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,38954,2775,1.68 [1.53-1.84],3.25855715672303e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,45489,3254,1.48 [1.35-1.63],3.842127134862416e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,39619,2822,1.27 [1.18-1.37],4.397445601501065e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,44645,3208,1.11 [1.09-1.14],1.2310894942559473e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,45494,3263,1.34 [1.25-1.44],2.242547792008735e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,39522,2809,1.60 [1.46-1.75],1.642388133478658e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,45624,3266,1.19 [1.12-1.25],1.5998029507281854e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,45892,3279,0.58 [0.50-0.66],1.5758483470697944e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,45489,3254,1.18 [1.15-1.22],6.060715802606202e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUCB2,Nucleobindin-2,45801,3271,1.25 [1.15-1.35],4.612394946019784e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,39549,2810,1.82 [1.69-1.96],9.902887296303873e-58
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGN,Mimecan,45494,3263,1.19 [1.11-1.28],2.894645138257178e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,45048,3226,1.15 [1.10-1.21],1.2720704109396483e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,45681,3278,0.73 [0.68-0.78],9.524516325377131e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,45287,3236,0.82 [0.78-0.86],7.56371074686965e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,39537,2827,2.14 [1.80-2.53],1.6088021815137753e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,45535,3268,1.58 [1.45-1.73],1.7163922967663817e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,45207,3245,1.23 [1.18-1.28],1.4808328154427509e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,45735,3272,1.78 [1.53-2.06],6.383435335804379e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,45892,3279,1.08 [1.06-1.11],7.401779315688359e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",P4HB,Protein disulfide-isomerase,45273,3244,1.22 [1.13-1.32],7.969492202243067e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,44645,3208,1.15 [1.09-1.21],1.2213476802801046e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,39522,2809,1.68 [1.55-1.83],1.0803172648260637e-33
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,38678,2758,1.20 [1.12-1.29],6.813841349649054e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,46041,3298,1.29 [1.20-1.39],6.782688580512542e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,38472,2750,1.35 [1.25-1.45],6.270624433298578e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,39652,2821,1.20 [1.14-1.26],3.227195561739428e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,45978,3292,1.52 [1.37-1.68],2.8936370992036223e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,45815,3283,1.25 [1.16-1.33],1.5024908294133598e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,44873,3209,1.25 [1.18-1.31],7.071280625103633e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,44915,3231,2.16 [2.02-2.32],9.866589882467113e-105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,45494,3263,1.51 [1.36-1.68],4.5036580653872283e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,45494,3263,1.43 [1.33-1.54],9.208944311157155e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,45489,3254,1.24 [1.17-1.31],1.2217388688770108e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,45624,3266,1.95 [1.75-2.16],1.4148055626700517e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,45962,3289,0.85 [0.79-0.91],5.007088058659484e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",45375,3249,1.17 [1.12-1.23],6.357456686156056e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,45888,3286,1.33 [1.25-1.41],6.946887358495557e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,45170,3250,2.37 [2.16-2.59],8.687595831363998e-76
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,38682,2777,1.64 [1.39-1.94],6.425091939971603e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC1,Plexin domain-containing protein 1,44402,3182,0.75 [0.67-0.84],5.109722185587138e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,45810,3277,1.34 [1.19-1.52],4.066676319435285e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",45287,3236,1.28 [1.19-1.38],1.5529250748718755e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,39652,2821,0.73 [0.65-0.82],2.275126057971369e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,44645,3208,1.33 [1.22-1.46],2.5448727720245366e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39549,2810,1.25 [1.15-1.36],2.203648172566366e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,39620,2822,1.63 [1.49-1.79],3.265140782087973e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,45752,3274,1.40 [1.27-1.54],4.8636938211844295e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,45660,3270,1.25 [1.19-1.32],6.532869822384273e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,45305,3259,1.89 [1.77-2.02],7.322914474796399e-75
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,39254,2802,1.63 [1.47-1.81],1.7721202501574725e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,44645,3208,1.19 [1.12-1.26],5.0480331019788856e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,39619,2822,1.38 [1.24-1.55],1.4109974337419956e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,39445,2811,0.83 [0.77-0.89],1.17510262472139e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,45425,3259,1.18 [1.11-1.26],6.111647057617433e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,45892,3279,1.46 [1.35-1.57],1.0017193025717456e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYY,Peptide YY,38317,2725,1.12 [1.08-1.17],1.4175355431104488e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,45735,3272,1.36 [1.28-1.44],4.293091265062106e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,39549,2810,1.44 [1.33-1.56],3.6531945313564953e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,45287,3236,1.16 [1.12-1.20],3.563743555798677e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,45287,3236,1.29 [1.22-1.36],1.0929487802472533e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,45213,3237,1.29 [1.21-1.36],3.2160498470900406e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,46041,3298,1.22 [1.16-1.29],3.634660934728889e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,46041,3298,1.17 [1.12-1.23],1.9274103168965177e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,45535,3268,1.36 [1.28-1.44],1.7993641095404144e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,45494,3263,1.59 [1.44-1.77],1.2521080671034274e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,45489,3254,1.19 [1.15-1.24],2.526550778924265e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,45892,3279,0.73 [0.66-0.81],4.2972584354062605e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,38752,2761,1.18 [1.10-1.26],5.78073663335213e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,39652,2821,1.69 [1.48-1.93],6.392900552301131e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,38374,2731,1.44 [1.27-1.63],8.80350019813464e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,39377,2804,1.69 [1.55-1.84],8.250371384635599e-33
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,45825,3280,1.49 [1.34-1.67],9.628609391895709e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,38587,2750,1.74 [1.55-1.94],2.9631705464157635e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,44402,3182,1.21 [1.14-1.27],9.105634010998587e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,45137,3223,1.46 [1.34-1.59],8.640002169321548e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,45872,3277,1.36 [1.22-1.52],1.4682055629141166e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,45133,3229,1.15 [1.08-1.21],1.908968736583428e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,44275,3153,1.61 [1.47-1.77],4.3365705116217013e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF1,Scavenger receptor class F member 1,46041,3298,1.18 [1.10-1.27],2.865231226563464e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,45534,3269,0.79 [0.75-0.82],6.3179045362829065e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,38752,2761,1.53 [1.34-1.76],6.807175514192742e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,45607,3272,1.15 [1.12-1.19],1.1390695096138105e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,45744,3267,1.32 [1.24-1.40],2.247194141149749e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,38437,2740,1.24 [1.16-1.33],2.176811053261916e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,38587,2750,1.32 [1.19-1.45],3.8728933430343854e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,46041,3298,1.27 [1.19-1.35],3.4153914481487445e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,39683,2839,0.56 [0.47-0.65],1.4104961287676444e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELL,L-selectin,39683,2839,0.70 [0.60-0.82],5.365197690642588e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,39449,2802,1.50 [1.36-1.66],6.328836016454475e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,38940,2786,3.19 [2.26-4.51],5.5155649587359965e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,39547,2832,2.19 [1.79-2.69],6.817756922224988e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,45978,3292,1.14 [1.09-1.19],5.985371632400249e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,39606,2836,1.63 [1.44-1.85],4.7396046555908605e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,46041,3298,1.16 [1.11-1.22],1.6498285029260954e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF2,Alpha-2-antiplasmin,38939,2787,0.54 [0.41-0.70],6.030536857811281e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,39606,2836,1.97 [1.63-2.38],3.527255482946045e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,44979,3208,1.21 [1.13-1.30],1.288208855176548e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP4,Secreted frizzled-related protein 4,38752,2761,0.81 [0.74-0.88],3.235717154963728e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,44402,3182,1.16 [1.10-1.21],4.294137994397822e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,44402,3182,1.27 [1.21-1.34],1.6240236667987553e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,45489,3254,1.14 [1.09-1.19],2.21374333750486e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,38959,2765,1.17 [1.10-1.25],2.549599052067601e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,39620,2822,1.87 [1.66-2.10],8.153780703143211e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,45547,3261,1.21 [1.14-1.30],3.645010246066623e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,45681,3278,1.34 [1.25-1.44],1.435235555160925e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,45425,3259,1.32 [1.21-1.45],1.240036113681978e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,45489,3254,1.76 [1.58-1.96],1.0905758757054674e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,38587,2750,1.28 [1.19-1.39],8.24798271171157e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,45387,3260,1.18 [1.11-1.26],6.785331429620615e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,44617,3192,1.19 [1.13-1.25],3.5910287485471856e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,45059,3219,1.10 [1.05-1.15],9.49330234604436e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,44617,3192,1.13 [1.07-1.19],6.356335256799171e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,45425,3259,1.15 [1.09-1.21],5.0763526738272664e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,44402,3182,1.21 [1.13-1.28],2.0152886464028003e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A5,Zinc transporter ZIP5,45425,3259,1.13 [1.07-1.19],7.472266812178554e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,38472,2750,0.63 [0.56-0.71],1.2497171960185124e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,45872,3277,0.71 [0.66-0.77],1.4638150781308585e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,45287,3236,1.52 [1.29-1.79],6.320516645571074e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,39445,2811,1.12 [1.06-1.17],7.555872746379155e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,45872,3277,1.24 [1.13-1.36],3.1971165724293337e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,45681,3278,1.22 [1.13-1.32],8.569420876640469e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,45672,3260,1.39 [1.32-1.47],1.9423808375639767e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,45605,3274,1.19 [1.14-1.25],4.5470085235393414e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMTN,Smoothelin,39444,2805,1.09 [1.05-1.13],7.996632653654233e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',39522,2809,1.16 [1.09-1.23],4.11878480499368e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",45494,3263,1.40 [1.29-1.51],5.964048804655337e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,44402,3182,1.31 [1.20-1.43],6.338814610747845e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORT1,Sortilin,45420,3249,1.22 [1.12-1.32],1.29772121777101e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARC,SPARC,45624,3266,1.12 [1.07-1.17],4.32274174737156e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,45494,3263,1.48 [1.39-1.58],8.816451937332905e-32
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,38752,2761,1.27 [1.15-1.39],1.6464016352609123e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,45425,3259,1.17 [1.11-1.22],8.817733691094025e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,45872,3277,1.17 [1.10-1.24],1.5352783205283069e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,45344,3251,1.72 [1.54-1.91],2.557757681303372e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,45681,3278,1.23 [1.14-1.33],8.31202294479483e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,45535,3268,1.60 [1.46-1.75],4.3251640898671635e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,45267,3236,1.65 [1.51-1.80],4.643621931010189e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,45420,3249,0.87 [0.85-0.89],2.3933307389157176e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,45660,3270,1.18 [1.10-1.27],4.650169357762408e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",46041,3298,1.64 [1.49-1.81],3.1622503460453352e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAB2,Stabilin-2,39620,2822,1.36 [1.20-1.53],1.4545670191057975e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,45892,3279,1.24 [1.16-1.32],1.4471390696459434e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,45425,3259,1.24 [1.18-1.30],1.0145523543973174e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,45494,3263,1.55 [1.42-1.69],3.503182365807673e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD5,Sushi domain-containing protein 5,38553,2751,0.77 [0.69-0.85],6.571123018071115e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,45287,3236,1.32 [1.22-1.44],5.1474648795578377e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,45968,3295,1.26 [1.14-1.39],6.761249331968348e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,39619,2822,1.28 [1.16-1.42],6.141364971732796e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,39619,2822,1.55 [1.37-1.74],3.194799411224623e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,45277,3253,1.22 [1.18-1.27],1.9228576661847872e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,45607,3272,1.45 [1.38-1.52],2.2896218578179436e-53
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,45433,3245,1.38 [1.31-1.46],1.308143331399855e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI,Tissue factor pathway inhibitor,45355,3245,1.23 [1.13-1.35],4.077231612430298e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,45486,3257,1.28 [1.20-1.36],3.149322623735364e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,45425,3259,1.35 [1.28-1.43],1.8325829646465727e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,45899,3284,1.34 [1.25-1.45],4.029385283164784e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,45624,3266,1.38 [1.26-1.51],2.6835993642332088e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,45494,3263,1.50 [1.39-1.62],6.862233721160033e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THOP1,Thimet oligopeptidase,45279,3242,1.31 [1.19-1.44],2.051721415924844e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,44977,3213,1.82 [1.65-2.02],5.350602679764925e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,45494,3263,1.51 [1.40-1.61],7.908114622376796e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,39449,2802,1.24 [1.13-1.36],2.296403108498415e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMSB10,Thymosin beta-10,45494,3263,1.12 [1.07-1.16],7.479345692946103e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,44583,3201,1.27 [1.18-1.36],2.0262842322755405e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,45137,3223,1.84 [1.70-2.00],2.9189785878381967e-48
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,45137,3223,1.40 [1.35-1.46],1.674380585598932e-65
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,45594,3270,1.16 [1.09-1.24],2.1306142711906207e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,45978,3292,1.32 [1.23-1.43],9.904357080292406e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,45463,3264,1.64 [1.49-1.80],2.5968556111686927e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,45624,3266,1.68 [1.55-1.82],2.6260212934797266e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,45535,3268,1.31 [1.21-1.43],1.6902113867938122e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,45535,3268,1.49 [1.35-1.64],9.338187621425069e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,45494,3263,1.75 [1.59-1.93],7.250508802785539e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,45494,3263,1.42 [1.33-1.51],1.96768069774179e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,45899,3284,1.24 [1.14-1.35],1.700307585157768e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,45137,3223,1.38 [1.32-1.45],1.0984423451282716e-39
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,45137,3223,1.28 [1.19-1.38],5.997958872261391e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,45425,3259,0.83 [0.79-0.87],4.87178736979252e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,45978,3292,0.74 [0.66-0.82],1.288738538308256e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,45681,3278,1.61 [1.44-1.80],2.2358339879156328e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,45964,3294,1.67 [1.51-1.85],2.2622427722610266e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,45137,3223,0.67 [0.63-0.72],6.123129171838802e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,45169,3246,1.42 [1.34-1.49],4.264766772846687e-37
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,45463,3264,1.52 [1.44-1.60],6.524180929815838e-53
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,45872,3277,1.12 [1.07-1.18],3.9101959754893984e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,39445,2811,1.11 [1.07-1.15],3.104940669780432e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,45624,3266,1.40 [1.26-1.57],1.041022280605076e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYMP,Thymidine phosphorylase,45195,3233,1.12 [1.07-1.17],2.7252395745679864e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,45137,3223,1.39 [1.28-1.50],3.727544501312046e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,45890,3283,0.80 [0.76-0.84],4.082223272522611e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,44645,3208,1.19 [1.13-1.26],2.9478407629092236e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,45826,3280,1.21 [1.15-1.28],5.417498053064775e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFD,Vascular endothelial growth factor D,45901,3288,1.22 [1.12-1.33],5.199419097437066e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,39426,2798,1.31 [1.24-1.38],5.008001162439221e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,45435,3254,1.53 [1.42-1.65],1.4305553123374578e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSNL1,Visinin-like protein 1,39522,2809,1.23 [1.13-1.33],2.5399579202871493e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,45809,3273,1.55 [1.45-1.66],2.164887112433855e-36
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,44978,3211,1.29 [1.19-1.39],9.415710846171695e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",45494,3263,1.25 [1.15-1.35],2.202862108374728e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,45793,3271,1.19 [1.14-1.25],2.6510331901889565e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,43194,3069,1.87 [1.76-2.00],6.395657837457862e-81
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",44981,3209,0.67 [0.63-0.73],1.41346003578211e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XCL1,Lymphotactin,45872,3277,1.15 [1.08-1.21],1.002512127545802e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,39522,2809,1.68 [1.48-1.91],1.0541849932892125e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,44645,3208,1.21 [1.13-1.28],8.030224205090248e-09
